'Halftime Report' Traders Advise Viewers On Medtronic, 23andMe And More

On CNBC's "Fast Money Halftime Report," Pete Najarian said Medtronic PLC MDT is really well run and it has a great free cash flow and unbelievable balance sheet.

Kevin O'Leary said the challenge for 23andMe Holding Co. ME is the customer acquisition cost. He sees it as a data company, but it's not the only company collecting human genome data. He doesn't see it as a trade. You would have to own it for the next three years.

Shannon Saccocia said Expedia Group Inc EXPE, Airbnb Inc ABNB and Tripadvisor Inc TRIP are going to trade sideways, until business travelers return, consumer demand is higher and we see more volumes.

Jason Snipe would close a long position in iShares Biotechnology ETF IBB and buy iShares US Transportation ETF IYT instead.